Adam C. McCall is an associate at BFA and advises investors concerning their rights and potential claims in complex securities class actions and shareholder derivative suits across the country.
Adam has substantial experience in all aspects of litigation, including investigating and drafting claims, briefing dispositive and other motions, oral argument, managing discovery efforts, taking depositions, working closely with experts, and trial.
Prior to joining BFA, Adam was an associate at a prominent securities litigation firm, where he litigated a wide array of complex cases. Adam’s efforts have helped result in the recovery of over $100 million for investors.
| Case | Type | Status |
|---|---|---|
| Apple Inc. | U.S. Securities Litigation | New |
| Bellring Brands, Inc. | U.S. Securities Litigation | New |
| Centene Corporation | U.S. Securities Litigation | New |
| Fortrea Holdings Inc. | U.S. Securities Litigation | New |
| Hims & Hers Health, Inc. | U.S. Securities Litigation | New |
| In re UiPath Securities Litigation | U.S. Securities Litigation | Pending |
| Neogen Corporation | U.S. Securities Litigation | New |
| Olo Inc. | Corporate Governance | New |
| Reddit, Inc. | U.S. Securities Litigation | New |
| Replimune Group | U.S. Securities Litigation | New |
| RxSight, Inc. | U.S. Securities Litigation | New |
| Sarepta Therapeutics, Inc. | U.S. Securities Litigation | New |
| Tiessen v. The Toronto-Dominion Bank et al. | U.S. Securities Litigation | Pending |